Deadline (Application): Pfizer Junior Investigator Global ATTR Amyloidosis Research ASPIRE

This competitive grant program seeks to support research conducted by Junior Investigators that advances medical knowledge in the understanding, diagnosis, and treatment of ATTR Amyloidosis through research focused in the following areas:

  • Epidemiologic evaluations for ATTR amyloidosis
  • Approaches for the early identification and follow up of ATTR amyloidosis patients
  • RW efficacy and safety of tafamidis in the clinical setting for the management of ATTR amyloidosis
  • Evaluation of patients with ATTR-CM presenting with a mixed phenotype (e.g. cardiomyopathy and polyneuropathy)
  • Pathophysiology

Individual projects requesting up to $75,000 USD/year for 1 to 2 years will be considered.

Click here for full details about this call [PDF].

Deadlines


Internal: March 7, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.

Funder: March 21, 2023. Contact email is amanda.j.stein@pfizer.com.

Time